In this week’s issue:
· amfAR, The Foundation for AIDS Research – Targeted Biomedical Research: Exploring the mechanisms for HIV persistence and the potential for HIV eradication
· AACR – Basic Cancer Research Fellowships
· AACR – FNAB Fellows Grant for Translational Pancreatic Cancer Research
· National Sanitarium Association – Innovative Research Program
· AACR – FNAB Career Development Award for Translational Cancer Research
· AACR – Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award
· The Centre for Drug Research and Development – PI and Partner Appreciation Reception
LOI Deadline: October 25, 2011
Through this Request for Proposals, amfAR wishes to support basic, clinical, and especially translational research exploring the mechanisms whereby HIV infection persists; the chronic nature of viral reservoirs and latency; and barriers to the eradication of HIV, with the potential goal of ultimately eliminating HIV infection. Understanding the mechanisms by which the virus is able to persist in the face of therapy is necessary in order to identify strategies that may interrupt viral persistence and ultimately lead to viral eradication.
Research grants will be given to nonprofit institutions worldwide to support investigator-led projects. Principal investigators must hold a doctoral-level degree and be affiliated with the applicant institution.
Grants will provide $208,333 for direct costs, plus up to 20 percent for indirect costs ($250,000 maximum total costs). The performance period for grants awarded under this RFP will be for two years, starting February 1, 2012.
LOI Deadline: October 31, 2011
AACR Basic Cancer Research Fellowships are one-year grants of up to $45,000 to support the salary and benefits of the fellow. A partial amount of funds, up to 25 percent of the total grant, may be designated for direct research expenses. Open to fellows who will be in the first, second or third year of their training at the start of the grant term. Research projects are restricted to basic cancer research. It is anticipated that multiple fellowships will be awarded.
Deadline: October 31, 2011
One-year grant of $35,000. Applicants must be in the first five years of a fellowship at the start of the grant term. Research projects are restricted to translational pancreatic cancer research that includes the use of human tissue and has implications for therapeutic application and individualized medicine. Proposed research must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not.
Deadline: November 1, 2011
NSA grants under the Innovative Research Program are intended to provide well-established investigators with start-up (venture) funding for innovative, emerging, and important new areas of research in the broad field of pulmonary science and medicine. Established fields of research that are supported by traditional funding agencies are not eligible for consideration.
It is expected that during the course of an NSA grant (of up to five years), the investigators will capture grants from traditional funding agencies, so that the project becomes self-sustaining by the end of the NSA funding period.
Renewal of NSA funding beyond the initial grant will not be considered.
NSA grants may provide funding of up to $1 million over a period of up to five years. The funds can be used to recruit investigators to an established research group and to provide them with initial salary support; for research equipment and operating expenses; and for the support of graduate students and research fellows.
Deadline: November 1, 2011
The AACR-FNAB Career Development Award for Translational Cancer Research is open to junior faculty who are in the first four years of a faculty appointment (at the start of the grant term). Research projects are restricted to translational cancer research focused on any individualized therapeutic area. Proposed project must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not. This is a two-year grant of $100,000 ($50,000 per year) for direct research expenses and salary support.
Deadline: November 15, 2011
The AACR-Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award provides a one-year grant of $50,000 to support direct research expenses, which may include the salary and benefits of the grant recipient, postdoctoral or clinical research fellows and/or research assistants, research/laboratory supplies, and equipment. The purpose of this award is to fund physician-scientists during the transition from a fellowship program to a faculty appointment. The Award is open to physicians (M.D., D.O., or international equivalent) or physicians holding a combined M.D./Ph.D. Applicants must be working in an oncology laboratory or clinical research setting in an academic medical institution and be in the last two years of his/her final subspecialty training. Research projects are restricted to translational cancer research.
Date: October 13, 2011 5:30 – 7:30pm
Location: Cecil Green Park House, 6251 Cecil Green Park Road, University of British Columbia
The Centre for Drug Research and Development is pleased to invite you to a special reception to express our appreciation to all of the researchers and partners who are so critical to our success.
This event is also a chance for all members of our life sciences community to learn of some of CDRD’s recent milestones and future goals, and to find out more about opportunities for engagement with CDRD.
Please visit the link above to register.
For further information, please contact:
Director, Communications via email@example.com
Tel: (604) 221-7750 ext. 223